Tilray

Cannabis In 2025: Inside America's Social, Economic, Wellness Transformation
Shareholder Lawsuit Challenges Tilray's Voting Tactics For Authorized Share Increase
Tilray Joins German Cannabis Fiesta With First Locally Grown Strains
Shareholder Lawsuit Challenges Tilray's Voting Tactics For Authorized Share Increase
Tilray Joins German Cannabis Fiesta With First Locally Grown Strains
Trump, Harris And Cannabis Stocks: Are Election Results Already Priced In?
Tilray CEO On Future Of Cannabis And Federal Rescheduling: 'We Did Not Sit Back And Wait'

Tilray Recent News

Weed Stocks Skyrocket, Could There Be More Upside? Analyst Draws Scenarios
The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's
Tilray's HEXO Acquisition Creates Canada's Top Cannabis Company With 44% Market Share Boost
Tilray (NASDAQ: TLRY) is making bold moves to secure a profitable future, and its latest acquisition of HEXO Corp. (NASDAQ: HEXO) has solidified its position as Canada's top cannabis company with a 44% market share
Diversification Pays Off: Tilray Beer Division Ranks 9th On List Of Top US Craft Brewers
Tilray Brands (NASDAQ: TLRY) may be a cannabis company, but it is officially among the largest craft brewers in the U.S. The firm's beer division ranks ninth on the Brewers Association’s annual report of the nation’s top craft companies based on beer sales volume in 2022.
Tilray Brands Set To Acquire Cannabis Co. HEXO Corp. In $250M Transaction
Tilray Brands Inc. (NASDAQ: TLRY) is expected to announce plans to acquire Canadian cannabis producer rival HEXO Corp (NASDAQ: HEXO) in a deal worth about $250 million on Monday after reporting its latest quarterly results.
Tilray Stock Soars Then Returns To Earth On Biden's Cannabis Pardon News, This Analyst Remains Neutral
On the heels of President Biden’s historic announcement that he was pardoning all federal marijuana possession convictions, Cantor Fitzgerald's
Tilray, Canopy Growth, Cronos And Aurora Get Bumped From Norway's $1.2 Trillion Wealth Fund, Here's Why
Norway's $1.2 trillion sovereign wealth fund will not invest directly or indirectly in four Canadian cannabis stocks because they produce recreational marijuana, which remains illegal within its borders.
Who Are The Most Impactful Cannabis Executives Of 2022? Top Award Show Will Determine Who's #1
After the awesome Cannabis Capital Conference in Miami during 4/20 week, Benzinga is ready to go again in Chicago on September 13-14. 
Tilray Launches Medical Cannabis Education Resource
Tilray Brands, Inc. (NASDAQ: TLRY), a Canada-based cannabis company, announced on Tuesday that subsidiary Tilray Medical has launched a new educational platform called WeCare-MedicalCannabis to provide education about the benefits of medical cannabis to consumers and medical practitioners
EXCLUSIVE: Irwin Simon, CEO, 'Tilray Will Own Canada, And It Will Get Bigger'
“Almost 4:20 on 4/20, pretty exciting,” said CNBC reporter Frank Holland as he welcomed the crowd at Benzinga’s Cannabis Capital Conference before interviewing Irwin Simon, CEO of Tilray inc. (NASDAQ
Tilray Stock Forecast 2025: Where Are Shares Of The Cannabis Co. Headed?
Tilray Inc (NASDAQ: TLRY), a Canadian pharmaceutical and cannabis company, is one of the most popular cannabis stocks out there. Back in 2018, the stock ran all the way to $148 before coming back down to the single digits.
Weed'n Whiskey: Why Tilray Thinks There Is Gold In Cannabis-Infused Whiskey
This article was originally published on Cannabis.net and appears here with permission.
Tilray's Growth In Export Business 'Positively' Impresses Analyst, Maintains Overweight
In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald offered an updated investment model for Tilray Inc. (NASDAQ: TLRY) in which he maintained an Overweight but lowered the price target for the stock to $6.90 from $7.40 on reduced estimates.</
Tilray And Budweiser Maker AB InBev Call Off Cannabis Beverage Partnership
The world’s leading brewer, AB InBev (NYSE: BUD), and Tilray (NASDAQ: TLRY) have ended their partnership, reported MJBizDaily.
Tilray CEO: Expand The Company's Medical Cannabis Business, 'Opportunities Are Tremendous'
Irwin Simon, CEO of Canada-based cannabis company Tilray (NASDAQ: TLRY), said Thursday on CNBC that the company intends to drive growth by building its medica
Analyst: Updating Tilray's Numbers Ahead Of Aug Qtr Print
Cantor Fitzgerald analyst Pablo Zuanic shared an update on Tilray's (NASDAQ: TLRY) Aug qtr sales estimates in his Thursday note.
Tilray Stockholders Approve Increase In Number Of Shares To Help Drive $4B In Revenue, Stock Trades Down
Shares of cannabis giant Tilray Inc. (NASDAQ: TLRY) (TSX: TLRY) are trading down on Friday afternoon, after the company reported that its stockholders have approved an increase in the number of authorized shares of its common stock.
This Cannabis Company Has A Better 1-Year Return Than Tesla, Facebook, GE And Ford
Investors that added Tilray Inc (NASDAQ: TLRY) to their portfolio one year ago are truly living the high life.
Tilray Acquires Majority Position In Amended MedMen Convertible Notes, Accelerating Path Into US Cannabis Market If Federal Legalization Occurs
Tilray, Inc. (NASDAQ: TLRY), and MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF), announced on Tuesday Tilray has acquired the majority of MedMen’s outstanding senior secured convertible notes
EXCLUSIVE: Tilray CEO Irwin Simon Discusses Earnings Report And Surge In Stock On Benzinga Cannabis Hour
Tilray Inc (NASDAQ: TLRY) CEO Irwin Simon spoke with Javier Hasse and Patrick Lane on Wednesday’s Cannabis Hour following the release of the company’s May quarter earni
Benzinga's Bulls And Bears Of The Week: Apple, AMC, Disney, GM, Tesla And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. The past week's bullish calls the iPhone maker, an aerospace giant and big banks. The EV leader, an entertainment giant and movie theater operators were among the bearish calls seen.
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week
Barron's Latest Picks And Pans: Curaleaf, Bank of America, Crocs, Sherwin-Williams And More
This weekend's Barron's cover story examines the prospects for the U.S. cannabis industry. Other featured articles discuss how cryptocurrency threatens the role of central banks, why steel stocks are due for a fall and whether the tech giants will thrive.
Walmart Earnings Awaited Tomorrow With Focus Turning Toward Online Sales
January isn’t usually a month where you see retail sales go through the roof, but these days investors are learning to expect the unexpected.
;

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved